99250696 - BELYMGO

Information

• Trademark
• 99250696

• Source

• Serial Number

  99250696

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  June 24, 2025
  4 months ago

• Transaction Date

  June 25, 2025
  4 months ago

• Status Date

  June 24, 2025
  4 months ago

• Location Date

  June 24, 2025
  4 months ago

• Status Code

  630

• Attorney Name

  Maury M Tepper III

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceuticals, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Case File Event Statements

• 6/24/2025 - 4 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/24/2025 - 4 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/24/2025 - 4 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR